Cleared Traditional

VIDAS D-DIMER EXCLUSION II (DEX2)

K112818 · bioMerieux, Inc. · Hematology
Jul 2012
Decision
307d
Days
Class 2
Risk

About This 510(k) Submission

K112818 is an FDA 510(k) clearance for the VIDAS D-DIMER EXCLUSION II (DEX2), a Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (Class II — Special Controls, product code DAP), submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on July 31, 2012, 307 days after receiving the submission on September 28, 2011. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7320.

Submission Details

510(k) Number K112818 FDA.gov
FDA Decision Cleared SESE
Date Received September 28, 2011
Decision Date July 31, 2012
Days to Decision 307 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code DAP — Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7320

Similar Devices — DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 56
HemosIL D-Dimer HS 500
K172903 · Instrumentation Laboratory CO · Nov 2017
STA? - Liatest? D-Di
K162227 · Diagnostica-Stago · Dec 2016
HemosIL D-Dimer HS
K160885 · Instrumentation Laboratory CO · Oct 2016
HemosIL D-Dimer HS
K151534 · Instrumentation Laboratory CO · Jul 2015
STA LIATEST D-DI
K141144 · Diagnostica-Stago · Sep 2014
STRATUS CS ACUTE CARE D-DIMER
K110303 · Siemens Healthcare Diagnostics · May 2011